Seguir
Laurens A van Meeteren
Laurens A van Meeteren
Dirección de correo verificada de uu.nl
Título
Citado por
Citado por
Año
The ins and outs of lysophosphatidic acid signaling
WH Moolenaar, LA van Meeteren, BNG Giepmans
Bioessays 26 (8), 870-881, 2004
6982004
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development
LA Van Meeteren, P Ruurs, C Stortelers, P Bouwman, MA van Rooijen, ...
Molecular and cellular biology, 2006
6582006
Vascular endothelial growth factor B controls endothelial fatty acid uptake
CE Hagberg, A Falkevall, X Wang, E Larsson, J Huusko, I Nilsson, ...
Nature 464 (7290), 917-921, 2010
5802010
Regulation and biological activities of the autotaxin–LPA axis
LA Van Meeteren, WH Moolenaar
Progress in lipid research 46 (2), 145-160, 2007
4262007
Regulation of endothelial cell plasticity by TGF-β
LA van Meeteren, P Ten Dijke
Cell and tissue research 347 (1), 177-186, 2012
4182012
Structural basis of substrate discrimination and integrin binding by autotaxin
J Hausmann, S Kamtekar, E Christodoulou, JE Day, T Wu, Z Fulkerson, ...
Nature structural & molecular biology 18 (2), 198-204, 2011
3362011
Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate
LA Van Meeteren, P Ruurs, E Christodoulou, JW Goding, H Takakusa, ...
Journal of Biological Chemistry 280 (22), 21155-21161, 2005
2512005
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
HMHG Albers, A Dong, LA van Meeteren, DA Egan, M Sunkara, ...
Proceedings of the National Academy of Sciences 107 (16), 7257-7262, 2010
2442010
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization
H Kawamura, X Li, K Goishi, LA van Meeteren, L Jakobsson, ...
Blood, The Journal of the American Society of Hematology 112 (9), 3638-3649, 2008
2092008
Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid
R Dusaulcy, C Rancoule, S Grès, E Wanecq, A Colom, C Guigné, ...
Journal of lipid research 52 (6), 1247-1255, 2011
2012011
Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis
Z Pamuklar, L Federico, S Liu, M Umezu-Goto, A Dong, M Panchatcharam, ...
Journal of Biological Chemistry 284 (11), 7385-7394, 2009
1852009
Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine
LA van Meeteren, F Frederiks, BNG Giepmans, MFF Pedrosa, ...
Journal of Biological Chemistry 279 (12), 10833-10836, 2004
1612004
Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity
CG Ferguson, CS Bigman, RD Richardson, LA van Meeteren, ...
Organic letters 8 (10), 2023-2026, 2006
1452006
Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma
NE Savaskan, L Rocha, MR Kotter, A Baer, G Lubec, LA Van Meeteren, ...
Cellular and Molecular Life Sciences 64, 230-243, 2007
1362007
Synthesis, structure− activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARγ, and …
GG Durgam, T Virag, MD Walker, R Tsukahara, S Yasuda, K Liliom, ...
Journal of medicinal chemistry 48 (15), 4919-4930, 2005
1342005
Discovery and optimization of boronic acid based inhibitors of autotaxin
HMHG Albers, LA van Meeteren, DA Egan, EW van Tilburg, ...
Journal of medicinal chemistry 53 (13), 4958-4967, 2010
1182010
NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation
S Koch, LA van Meeteren, E Morin, C Testini, S Weström, H Björkelund, ...
Developmental cell 28 (6), 633-646, 2014
1162014
Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting
LA van Meeteren, M Thorikay, S Bergqvist, E Pardali, CG Stampino, ...
Journal of Biological Chemistry 287 (22), 18551-18561, 2012
1162012
ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis
Z Liu, F Lebrin, JA Maring, S van den Driesche, S van der Brink, ...
PloS one 9 (1), e86273, 2014
912014
TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy
L A. van Meeteren, MJ Goumans, P ten Dijke
Current pharmaceutical biotechnology 12 (12), 2108-2120, 2011
912011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20